A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.
Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
MIRI PI Patrick Catalano, MD, has been awarded an R21 from the NIH/NICHD as Multi-Site PI for a two-year study entitled, “Impact of a Postpartum Lifestyle Intervention on Lactation Outcomes, Breastmilk Composition and Infant Growth.”
MIRI PI Dr. Michael House and his team members received a COVID-19 Rapid Response SeeD Funding Grant. This new funding program is intended to fast track innovative research proposals that directly address the urgent needs of the COVID-19 pandemic.
A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.